“Hepatitis+C”的搜索结果，显示 371-380 项，共有 11145 项

1. 血液科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

2. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

3. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to understanding the mechanisms of weight gain in patients following liver transplantation, action, and indicate ...

4. 血液科- 临床试验- 妙佑医疗国际

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

5. 血液科- 临床试验- 妙佑医疗国际

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

6. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   neoadjuvant chemotherapy followed by standard surgery (ILND); or C. neoadjuvant chemoradiotherapy followed by standard surgery (ILND). After ILND, patients ...

8. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

9. 头颈癌- 医生与科室- 妙佑医疗国际

   显示$起始范围- $结束范围/源自可用$可用医生. 姓氏首字母: C. William J. Casey, ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...